Company rolls out 9000 job cuts

Posted 11 September 2025 AM

Novo Nordisk will reduce its global workforce by 9,000 as part of a company-wide transformation to simplify operations, speed decision-making and redirect resources to growing its obesity and diabetes business.

The bulk of the job losses, around 5000, will be in Denmark where the company is headquartered, but cuts are expected "across the company" delivering savings of around DKK8 billion (AU$1.9 billion) by the end of 2026.

To see the whole article please log in.

Log in with your member email for full access.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Email

Retype password

Not a member? Sign up here